Provider
QP51-23 Commercial Pharmacy Benefit Exclusion for Aponvie™, Iheezo™, Omisirge®, and Qalsody™
Program effective Date: Jun 14, 2023
Documents & Forms Results
Displaying 1611 - 1620 of 3108 results
Provider
QP52-23 MHCP Pharmacy Benefit Exclusion for Iheezo™, Omisirge®, and Qalsody™
Program effective Date: Jun 14, 2023
Provider
QP53-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Program effective Date: Jun 14, 2023
Provider
QP54-23 MHCP Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 1, 2023
Program effective Date: Jun 14, 2023
Provider
QP55-23 Change in Processing for Replacement Claims
Program effective Date: Jun 14, 2023
Provider
QP48-23 Update for New to Market Medical Drugs: delandistrogene moxeparvovec and epcoritamab
Program effective Date: Jun 14, 2023
Provider
QP49-23 Register for Webinar | Trauma-Informed Care 101 | Thursday, June 29, 5-6:30 pm
Program effective Date: Jun 14, 2023
Provider
QP50-23 Fetal Alcohol Syndrome Education Opportunity
Program effective Date: Jun 14, 2023
Provider
P46-23 Services Removed from the Commercial Prior Authorization List
Program effective Date: Jun 01, 2023
Provider
P23R1-23 Laboratory Services: Lab Rebundling Reimbursement Policy will not be Updated
Program effective Date: Jun 01, 2023